Investigational drug · Phase 3
0.76% Na MFP
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Plaque, Gingivitis, Bacterial Load Reduction.
Phase 3Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
0 still active
All registered trials
39
Any phase or sponsor naming "0.76% Na MFP"
First trial start
2026
Mar 1, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "0.76% Na MFP", any sponsor or status.
- Phase 317
Conditions studied
As listed on its trial records.
- Plaque
- Gingivitis
- Bacterial Load Reduction
Approved drugs for the same conditions: Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "0.76% Na MFP" as an intervention, largest first.
Procter and GambleIndustry
NCT03970759 · 2,890 participants · Start Jan 8, 2018 · Primary completion Nov 30, 2018
Drug: Stannous Fluoride Dentifrice; Positive control dentifrice and 1 more · For: Gingivitis
Sites: Cincinnati, Ohio
Procter and GambleIndustry
NCT04006483 · 2,359 participants · Start Jan 8, 2018 · Primary completion Nov 30, 2018
Drug: Stannous fluoride dentifrice; Positive control dentifrice and 1 more · For: Dental Plaque
Sites: Cincinnati, Ohio
Procter and GambleIndustry
NCT04005417 · 1,036 participants · Start Jan 8, 2018 · Primary completion Nov 30, 2018
Drug: Stannous fluoride dentifrice; Positive control dentifrice and 1 more · For: Dentine Hypersensitivity
Sites: Cincinnati, Ohio
- Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal HypersensitivityPivotal-lookingCompleted
GlaxoSmithKlineGSK (GSK)
NCT02832375 · 242 participants · Start Mar 1, 2016 · Primary completion May 1, 2016
Drug: stannous fluoride; sodium monofluorophosphate · For: Dentin Sensitivity
Sites: Las Vegas, Nevada
- Comparative Efficacy of Floss and Essential Oil/CPC+Zn Mouthwashes in Reducing Dental Plaque and GingivitisPivotal-lookingCompleted
Colgate PalmoliveIndustry
NCT07029438 · 228 participants · Start Jul 7, 2025 · Primary completion Oct 16, 2025
Drug: Mouthwash; Toothpaste · For: Dental Plaque; Gingivitis
Sites: Fort Wayne, Indiana
- A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque RemovalPivotal-lookingCompleted
HALEONIndustry
NCT05654662 · 197 participants · Start Feb 20, 2023 · Primary completion Nov 30, 2023
Drug: Corsodyl Original Dentifrice; Colgate Cavity Protection Dentifrice · For: Gingivitis; Dental Plaque
Sites: Bristol, United Kingdom
Procter and GambleIndustry
NCT04006470 · 172 participants · Start Jan 8, 2018 · Primary completion Nov 30, 2018
Drug: Stannous fluoride dentifrice; Positive control dentifrice and 1 more · For: Enamel Erosion
Sites: Cincinnati, Ohio
- A Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival HealthPivotal-lookingCompleted
HALEONIndustry
NCT07169188 · 154 participants · Start Sep 9, 2025 · Primary completion Dec 23, 2025
Drug: Test Fluoride Toothpaste; Colgate Cavity Protection Toothpaste · For: Dental Plaque; Gingivitis
Sites: Mississauga, Canada
- Six Month Plaque and Gingivitis Study Using Colgate Total ToothpastePivotal-lookingCompleted
Colgate PalmoliveIndustry
NCT02080273 · 135 participants · Start Mar 2013 · Primary completion Nov 2013
Drug: Colgate Cavity Protection toothpaste; Colgate Total toothpaste and 1 more · For: Dental Plaque; Gingivitis
Sites: Ratchathewi, Thailand
- Evaluating Gingivitis and Systemic BiomarkersPivotal-lookingCompleted
Procter and GambleIndustry
NCT06962956 · 135 participants · Start Apr 30, 2025 · Primary completion Oct 31, 2025
Drug: 0.76% Sodium Monofluorophosphate Dentifrice; 0.454% Stannous Fluoride Dentifrice and 1 more · For: Gingivitis
Sites: Fort Wayne, Indiana
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.